Lasa Supergenerics Quarterly Results

Pros & Cons

POSITIVES

Revenue growth indicates a consistent demand for Lasa Supergenerics' products, aligning with industry trends towards healthcare and pharmaceuticals.
Improved profit margins demonstrate effective cost management strategies and operational efficiencies.
Increased R&D investment suggests a commitment to innovation, positioning the company for future market opportunities.

NEGATIVES

Declining net profit in the latest quarter raises concerns about profitability sustainability amidst rising raw material costs.
Operating expenses have surged, outpacing revenue growth and potentially squeezing margins if not controlled.
Market competition is intensifying, which may pressure pricing strategies and erode market share in upcoming quarters.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	24.30	26.66	22.82	30.84	39.39	33.08	39.14	20.01
Expenses	23.26	25.61	26.80	29.04	38.60	32.29	35.73	20.51
Operating Profit	1.04	1.05	-3.98	1.80	0.79	0.79	3.41	-0.50
Other Income	0.08	0	0.01	0.01	1.95	0.14	2.39	0.13
Interest	0.56	0.44	0.56	0.87	1.24	0.47	0.11	0.03
Depreciation	2.68	2.68	2.66	2.79	2.81	2.80	3.90	1.57
Profit Before Tax	-2.11	-2.06	-15.97	-1.86	-1.31	5.91	-22.12	-22.54
Tax	-2.09	-0.61	-0.67	0.87	1.91	0.42	-7.83	-1.42
Net Profit	-0.02	-1.46	-15.30	-2.73	-3.23	5.49	-14.29	-21.12
Eps in Rs	0	-0.29	-3.05	-0.55	-0.64	1.10	-2.85	-4.22